Gisondi, P., F. Loconsole, P. Raimondo, and R. Ravasio. “Cost Per Responder for Risankizumab Vs Secukinumab in Patients With Moderate-to-Severe Plaque Psoriasis in Italy”. Global and Regional Health Technology Assessment, vol. 8, no. 1, Sept. 2021, pp. 120-3, doi:10.33393/grhta.2021.2258.